Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86,325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with advanced non-small cell lung cancer: A real-world retrospective cohort study.
Chen S, Wei H, Zhao W, Jiang W, Ning R, Zhou S, Tan L, Wang H, Su C, He J, Zeng A, Zhao Y, Yu Q. Chen S, et al. Front Immunol. 2022 Dec 7;13:1059995. doi: 10.3389/fimmu.2022.1059995. eCollection 2022. Front Immunol. 2022. PMID: 36569915 Free PMC article.
SLC40A1+ macrophages contribute to the immunosuppressive tumor microenvironment in EGFR-mutated lung cancer.
Song X, Li Z, Wang X, Du H, Jia Y, Chen S, Xiong A, Li W, Li X, Cheng L, Zhao C, Wang L, Gao G, Chen X, Wu C, Zhao Z, Ren S, Zhou C, Wu F. Song X, et al. Among authors: chen s. Sci Bull (Beijing). 2024 Nov 12:S2095-9273(24)00810-7. doi: 10.1016/j.scib.2024.11.012. Online ahead of print. Sci Bull (Beijing). 2024. PMID: 39580243 No abstract available.
86,325 results
You have reached the last available page of results. Please see the User Guide for more information.